{"id":391563,"date":"2026-09-23T10:46:11","date_gmt":"2026-09-23T10:46:11","guid":{"rendered":"https:\/\/www.europesays.com\/se\/391563\/"},"modified":"2026-09-23T10:46:11","modified_gmt":"2026-09-23T10:46:11","slug":"forvaltaren-om-bonesupport-goda-mojligheter-till-dubbling","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/391563\/","title":{"rendered":"F\u00f6rvaltaren om Bonesupport: &#8221;Goda m\u00f6jligheter till dubbling&#8221;"},"content":{"rendered":"<p>Stor tro p\u00e5 Bonesupport<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Fondens st\u00f6rsta innehav \u00e4r medicinteknikbolaget <strong>Bonesupport<\/strong>, vars produkter anv\u00e4nds f\u00f6r att fylla bendefekter och gradvis ombildas till patientens eget ben. Lancelot Sverige har \u00e4gt aktien sedan 2017.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Aktien \u00e4r ned omkring 50% fr\u00e5n tidigare toppniv\u00e5er, men Bertilsson \u00e4r fortsatt positiv. Han pekar bland annat p\u00e5 en tillv\u00e4xt p\u00e5 \u00f6ver 30%, f\u00f6rb\u00e4ttrade marginaler, positiva studieresultat och ett allt starkare kassafl\u00f6de.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">&#8221;De har levererat p\u00e5 det de har sagt historiskt.&#8221;<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Att han f\u00f6ljt bolaget n\u00e4ra under m\u00e5nga \u00e5r \u00e4r ocks\u00e5 en viktig del i hans syn p\u00e5 aktien. Bertilsson tr\u00e4ffar regelbundet bolagsledningen och har dessutom pratat med l\u00e4kare som anv\u00e4nder produkterna.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">&#8221;Jag har pratat med s\u00e5 m\u00e5nga personer som anv\u00e4nt det och sett bra resultat. D\u00e5 beh\u00f6ver man inte bli lika orolig.&#8221;<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Bolaget har ocks\u00e5 b\u00f6rjat \u00e5terk\u00f6pa egna aktier.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">&#8221;Jag tror helt enkelt att det \u00e4r bara att forts\u00e4tta ha lite is i magen och t\u00e5lamod.&#8221;<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Bertilsson ser goda m\u00f6jligheter f\u00f6r en dubbling p\u00e5 tre \u00e5rs sikt.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">&#8221;Ja, det tror jag absolut finns god m\u00f6jlighet till&#8221;, s\u00e4ger han.<\/p>\n","protected":false},"excerpt":{"rendered":"Stor tro p\u00e5 Bonesupport Fondens st\u00f6rsta innehav \u00e4r medicinteknikbolaget Bonesupport, vars produkter anv\u00e4nds f\u00f6r att fylla bendefekter och&hellip;\n","protected":false},"author":2,"featured_media":391564,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[65],"tags":[7960,12417,72,6602,70,71,4837,6631,35543,34,31,33,32,30],"class_list":["post-391563","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ekonomi","tag-asmodee","tag-bonesupport","tag-business","tag-camurus","tag-economy","tag-ekonomi","tag-electrolux-professional","tag-eli-lilly","tag-lancelot-sverige-a","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/117319957646497304","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/391563","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=391563"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/391563\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/391564"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=391563"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=391563"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=391563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}